These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7660935)

  • 1. Renal clearances of purine bases and oxypurinol during glucose infusion.
    Moriwaki Y; Yamamoto T; Takahashi S; Nasako Y; Hada T; Higashino K
    Adv Exp Med Biol; 1994; 370():39-42. PubMed ID: 7660935
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of glucose infusion on the renal transport of purine bases and oxypurinol.
    Moriwaki Y; Yamamoto T; Takahashi S; Suda M; Higashino K
    Nephron; 1995; 69(4):424-7. PubMed ID: 7777107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of lactate infusion on renal transport of purine bases and oxypurinol.
    Yamamoto T; Moriwaki Y; Takahashi S; Nasako Y; Higashino K
    Nephron; 1993; 65(1):73-6. PubMed ID: 8413795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of angiotensin II infusion on renal excretion of purine bases and oxypurinol.
    Moriwaki Y; Yamamoto T; Tsutsumi Z; Takahashi S; Hada T
    Metabolism; 2002 Jul; 51(7):893-5. PubMed ID: 12077737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of glucagon on renal excretion of oxypurinol and purine bases.
    Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Hiroishi K; Yamakita J; Nakano T; Higashino K
    J Rheumatol; 1997 Apr; 24(4):708-13. PubMed ID: 9101506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xanthine-containing calculi during allopurinol therapy.
    Kranen S; Keough D; Gordon RB; Emmerson BT
    J Urol; 1985 Apr; 133(4):658-9. PubMed ID: 3981718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of DL-sodium lactate infusion on excretion of purine bases and oxypurinol.
    Yamamoto T; Moriwaki Y; Takahashi S; Nasako Y; Higashino K
    Int J Clin Pharmacol Ther Toxicol; 1993 Dec; 31(12):588-92. PubMed ID: 8314359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of losartan potassium, an angiotensin II receptor antagonist, on renal excretion of oxypurinol and purine bases.
    Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Hada T
    J Rheumatol; 2000 Sep; 27(9):2232-6. PubMed ID: 10990239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption and metabolism of allopurinol and oxypurinol by rat jejunum in vitro: effects on uric acid transport.
    Shaw MI; Parsons DS
    Clin Sci (Lond); 1984 Mar; 66(3):257-67. PubMed ID: 6692658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of furosemide on renal excretion of oxypurinol and purine bases.
    Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Hada T
    Metabolism; 2001 Feb; 50(2):241-5. PubMed ID: 11229436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Difference of the plasma concentration and urinary excretion of allopurinol, oxypurinol, and purine bases between dietary intake and fasting.
    Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Yamakita J; Higashino K
    Int J Clin Pharmacol Ther; 1996 Apr; 34(4):157-62. PubMed ID: 8861734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma concentrations and urinary excretion of purine bases (uric acid, hypoxanthine, and xanthine) and oxypurinol after rigorous exercise.
    Kaya M; Moriwaki Y; Ka T; Inokuchi T; Yamamoto A; Takahashi S; Tsutsumi Z; Tsuzita J; Oku Y; Yamamoto T
    Metabolism; 2006 Jan; 55(1):103-7. PubMed ID: 16324927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deamination of guanine to xanthine: a metabolic pathway of underestimated importance in human purine catabolism?
    van Waeg G; Niklasson F; de Verdier CH
    Adv Exp Med Biol; 1986; 195 Pt A():425-30. PubMed ID: 3728173
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of amino acids on the excretions of purine bases and oxypurinol.
    Yamamoto T; Moriwaki Y; Takahashi S; Yamakita J; Higashino K
    Nephron; 1996; 73(1):41-7. PubMed ID: 8742955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of allopurinol on caffeine disposition in man.
    Grant DM; Tang BK; Campbell ME; Kalow W
    Br J Clin Pharmacol; 1986 Apr; 21(4):454-8. PubMed ID: 3754760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allopurinol or oxypurinol in heart failure therapy - a promising new development or end of story?
    Reyes AJ; Leary WP
    Cardiovasc Drugs Ther; 2005 Oct; 19(5):311-3. PubMed ID: 16382292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of allopurinol and its metabolite oxypurinol after oral administration of allopurinol alone or associated with benzbromarone in man. Simultaneous assay of hypoxanthine and xanthine by gas chromatography-mass spectrometry.
    Lartigue-Mattei C; Chabard JL; Ristori JM; Bussiere JL; Bargnoux H; Petit J; Berger JA
    Fundam Clin Pharmacol; 1991; 5(7):621-33. PubMed ID: 1778540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacokinetics of injectable allopurinol in newborns with the hypoplastic left heart syndrome.
    McGaurn SP; Davis LE; Krawczeniuk MM; Murphy JD; Jacobs ML; Norwood WI; Clancy RR
    Pediatrics; 1994 Dec; 94(6 Pt 1):820-3. PubMed ID: 7970996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral uric acid, xanthine, and hypoxanthine after ischemia: the effect of allopurinol.
    Nihei H; Kanemitsu H; Tamura A; Oka H; Sano K
    Neurosurgery; 1989 Oct; 25(4):613-7. PubMed ID: 2797398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the transport of xanthine dehydrogenase inhibitors by the urate transporter ABCG2.
    Nakamura M; Fujita K; Toyoda Y; Takada T; Hasegawa H; Ichida K
    Drug Metab Pharmacokinet; 2018 Feb; 33(1):77-81. PubMed ID: 29342419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.